Clinical trial
Phase II Trial- Weekly Taxotere and Topotecan for Recurrent Ovarian, Primary Peritoneal, Endometrial and Uterine Cancers
NCT00231855 is registered in ClinicalTrials.gov with Montefiore Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Trial- Weekly Taxotere and Topotecan for Recurrent Ovarian, Primary Peritoneal, Endometrial and Uterine Cancers
- Lead sponsor
- Montefiore Medical Center
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2004
- Completion date
- March 31, 2007
- Enrollment
- 31
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.